Nubiyota

MET Pipeline

NuBiyota is developing a pipeline of multi-strain microbiome therapeutic composition candidates to treat a range of medical conditions and diseases, using its proprietary Microbial Ecosystem Therapeutics platform.
Please select a wpDataTable.
The MET 3 phase II study is in the US all other studies are done in Canada.